Prokarium
Prokarium is a London-based biotech company focused on developing vaccines and immunotherapies based on engineering biology.
Total raised
€33M
€33,129,505
Funding rounds
2
Investors
1
distinct backers
Active since
2019-09
latest 2023-02
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood27
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 14y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-09 | Other | €28M | — | View deal → |
| 2019-10-01 | Other | €5.2M | Wellcome Trust | View deal → |
Investors
1Related news
- Prokarium Raises $30M in Fundingfinsmes.com · 2023-02
- finsmes.com